News for Intercept Pharmaceuticals, Inc. (ICPT)

**media[552088]**

MORRISTOWN, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- The Gastrointestinal Drugs Advisory Committee (GIDAC) of the U.S. Food and Drug Administration (FDA)...

Analysis compares results from confirmatory trial COBALT in PBC with real-world data from a pre-specified external control group utilizing the Komodo...

SAB BIO Appoints Lucy To as Chief Financial Officer ...

PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial

Arvinas appoints new CFO with extensive biopharma experience

- Awards Mr. Saik an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) - NEW HAVEN, Conn., June 24, 2024 (GLOBE NEWSWIRE) -- Arvinas,...

Results show combination of OCA 5-10 mg and bezafibrate 400 mg normalizes multiple serum biomarkers that are associated with improved transplant-free and...

OCA significantly reduces ALT and AST, liver biomarkers associated with poor clinical outcomes, as early as Week 2 in both OCA treatment groups, and by...

Strengthening Operational Efficiency and Execution towards Sustainable Accessibility for Diverse Populations within Global Healthcare Systems...

Neurogene Inc. has seen a significant increase in its share price since joining the Nasdaq in December 2023. Read more on NGNE stock here.

Appointment comes as Vivani prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management Under Bradbury’s leadership as CEO, Amylin...

sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from...

FOSTER CITY, Calif., Nov. 27, 2023 -- Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious...

Insights from Jefferies Group (Trades, Portfolio)'s Latest 13F Filing for Q3 2023 Jefferies Group (Trades, Portfolio), under the leadership of CEO Richard Hand

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.

4 big analyst cuts: Apple loses buy rating on slack iPhone demand

Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades for Apple, Revolve, Rain Therapeutics, and Intercept Pharmaceuticals. Loop Capital downgraded Apple (NASDAQ:AAPL) to Hold from Buy with a price target of $180.00. The firm sees a material downside risk to revenue (both iPhone and overall) estimates for Q3, relative to both the company’s guidance and Street forecasts.

U.S. stocks extended gains toward the end of trading, with the Dow Jones gaining more than 400 points on Wednesday. The Dow traded up 1.22% to 33,413.93 while the NASDAQ rose 1.31% to 12,505.33. The S&P 500, also rose, gaining, 1.19% to 4,158.84.